A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.

Director Carladenise Edwards sold 67,160 shares on May 18, 2026 for approximately $230,000 at a weighted average price of about $3.42 per share. The article is a straightforward insider transaction disclosure with no accompanying operational or financial update. Market impact is likely limited, though the sale may be viewed as a mild governance signal.

Analysis

Director Carladenise Edwards sold 67,160 shares on May 18, 2026 for approximately $230,000 at a weighted average price of about $3.42 per share. The article is a straightforward insider transaction disclosure with no accompanying operational or financial update. Market impact is likely limited, though the sale may be viewed as a mild governance signal.